These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10459686)

  • 41. Changes in EEG power density of non-REM sleep in depressed patients during treatment with trazodone.
    Van Bemmel AL; Beersma DG; Van den Hoofdakker RH
    J Affect Disord; 1995 Oct; 35(1-2):11-9. PubMed ID: 8557883
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trazodone-induced severe headache.
    Chen HC; Tsai SJ
    Psychiatry Clin Neurosci; 2011 Dec; 65(7):681-2. PubMed ID: 22176292
    [No Abstract]   [Full Text] [Related]  

  • 43. Insomnia treatment in the third trimester of pregnancy reduces postpartum depression symptoms: a randomized clinical trial.
    Khazaie H; Ghadami MR; Knight DC; Emamian F; Tahmasian M
    Psychiatry Res; 2013 Dec; 210(3):901-5. PubMed ID: 23993464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trazodone-induced parkinsonism in a middle-aged male: A case report.
    Ali HT; Soliman ZA; Aborigiba F; Caprara ALF; Rissardo JP
    Afr Health Sci; 2024 Mar; 24(1):206-212. PubMed ID: 38962328
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melatonin and pro-hypnotic effectiveness of the antidepressant Trazodone: A preliminary evaluation in insomniac mood-disorder patients.
    Giannaccini G; Masala I; Palego L; Betti L; Pacciardi B; Palagini L; Luchini F; Belli S; Lucacchini A; Mauri M
    Clin Biochem; 2016 Oct; 49(15):1152-1158. PubMed ID: 27374436
    [No Abstract]   [Full Text] [Related]  

  • 46. Serotonin syndrome produced by paroxetine and low-dose trazodone.
    Reeves RR; Bullen JA
    Psychosomatics; 1995; 36(2):159-60. PubMed ID: 7724720
    [No Abstract]   [Full Text] [Related]  

  • 47. Efficacy of oral trazodone slow release following intravenous administration in depressed patients: a naturalistic study.
    Fiorentini A; Rovera C; Caldiroli A; Arici C; Prunas C; Di Pace C; Paletta S; Pozzoli SM; Buoli M; Altamura AC
    Riv Psichiatr; 2018; 53(5):261-266. PubMed ID: 30353201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rediscovering trazodone for the treatment of major depressive disorder.
    Fagiolini A; Comandini A; Catena Dell'Osso M; Kasper S
    CNS Drugs; 2012 Dec; 26(12):1033-49. PubMed ID: 23192413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estimation of an Appropriate Dose of Trazodone for Pediatric Insomnia and the Potential for a Trazodone-Atomoxetine Interaction.
    Oggianu L; Ke AB; Chetty M; Picollo R; Petrucci V; Calisti F; Garofolo F; Tongiani S
    CPT Pharmacometrics Syst Pharmacol; 2020 Feb; 9(2):77-86. PubMed ID: 31808613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Trazodone Contramid® in clinical practice: personalizing antidepressant intervention].
    Fagiolini A; Amodeo G; Goracci A; Blardi P
    Riv Psichiatr; 2016; 51(4):123-128. PubMed ID: 27727261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Probable interaction between trazodone and carbamazepine.
    Sánchez-Romero A; Mayordomo-Aranda A; García-Delgado R; Durán-Quintana JA
    Pharmacopsychiatry; 2011 Jun; 44(4):158-9. PubMed ID: 21710406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trazodone addition for insomnia in venlafaxine-treated, depressed inpatients: a semi-naturalistic study.
    Bertschy G; Ragama-Pardos E; Muscionico M; Aït-Ameur A; Roth L; Osiek C; Ferrero F
    Pharmacol Res; 2005 Jan; 51(1):79-84. PubMed ID: 15519538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trazodone: properties and utility in multiple disorders.
    Mittur A
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):181-96. PubMed ID: 22115401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
    Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
    Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Occurrence of trazodone-induced delirium.
    Lennkh C; Fischer P; Küfferle B; Kasper S
    Int Clin Psychopharmacol; 1998 Sep; 13(5):225-8. PubMed ID: 9817628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trazodone--a comparison of single night-time and divided daily dosage regimens.
    Brooks D; Prothero W; Bouras N; Bridges PK; Jarman CM; Ankier SI
    Psychopharmacology (Berl); 1984; 84(1):1-4. PubMed ID: 6436874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Open pilot study of gabapentin versus trazodone to treat insomnia in alcoholic outpatients.
    Karam-Hage M; Brower KJ
    Psychiatry Clin Neurosci; 2003 Oct; 57(5):542-4. PubMed ID: 12950711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects.
    Karhu D; Gossen ER; Mostert A; Cronjé T; Fradette C
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):730-43. PubMed ID: 22122815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.
    Kallepalli BR; Bhatara VS; Fogas BS; Tervo RC; Misra LK
    J Child Adolesc Psychopharmacol; 1997; 7(2):97-107. PubMed ID: 9334895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A review of the evidence for the efficacy and safety of trazodone in insomnia.
    Mendelson WB
    J Clin Psychiatry; 2005 Apr; 66(4):469-76. PubMed ID: 15816789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.